213 related articles for article (PubMed ID: 19048358)
1. A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo.
Han M; He CX; Fang QL; Yang XC; Diao YY; Xu DH; He QJ; Hu YZ; Liang WQ; Yang B; Gao JQ
Pharm Res; 2009 Apr; 26(4):926-35. PubMed ID: 19048358
[TBL] [Abstract][Full Text] [Related]
2. MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.
Zhu Y; Jiang H; Zhang C; He QJ; Yang B; Li LJ; Zhu H
Pharmazie; 2009 Dec; 64(12):823-8. PubMed ID: 20095141
[TBL] [Abstract][Full Text] [Related]
3. P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.
Zhang C; Zhu H; Yang X; Lou J; Zhu D; Lu W; He Q; Yang B
J Cancer Res Clin Oncol; 2010 Mar; 136(3):437-45. PubMed ID: 19727814
[TBL] [Abstract][Full Text] [Related]
4. Potent antitumor activity of 10-methoxy-9-nitrocamptothecin.
Luo P; He Q; He X; Hu Y; Lu W; Cheng Y; Yang B
Mol Cancer Ther; 2006 Apr; 5(4):962-8. PubMed ID: 16648567
[TBL] [Abstract][Full Text] [Related]
5. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
Zhang X; Gan Y; Gan L; Nie S; Pan W
J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
[TBL] [Abstract][Full Text] [Related]
6. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
8. Layer-by-layer nanoencapsulation of camptothecin with improved activity.
Parekh G; Pattekari P; Joshi C; Shutava T; DeCoster M; Levchenko T; Torchilin V; Lvov Y
Int J Pharm; 2014 Apr; 465(1-2):218-27. PubMed ID: 24508806
[TBL] [Abstract][Full Text] [Related]
9. Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization.
Ramasamy T; Choi JY; Cho HJ; Umadevi SK; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2015 Jun; 32(6):1947-56. PubMed ID: 25471199
[TBL] [Abstract][Full Text] [Related]
10. Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin.
Zhou YY; Du YZ; Wang L; Yuan H; Zhou JP; Hu FQ
Int J Pharm; 2010 Jun; 393(1-2):143-51. PubMed ID: 20420886
[TBL] [Abstract][Full Text] [Related]
11. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.
Choudhury H; Gorain B; Karmakar S; Biswas E; Dey G; Barik R; Mandal M; Pal TK
Int J Pharm; 2014 Jan; 460(1-2):131-43. PubMed ID: 24239580
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
[TBL] [Abstract][Full Text] [Related]
13. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
[TBL] [Abstract][Full Text] [Related]
15. Well-defined hydroxyethyl starch-10-hydroxy camptothecin super macromolecule conjugate: cytotoxicity, pharmacodynamics research, tissue distribution test and intravenous injection safety assessment.
Li G; Zhao M; Zhao L
Drug Deliv; 2016 Oct; 23(8):2860-2868. PubMed ID: 26836216
[TBL] [Abstract][Full Text] [Related]
16. Antimetastatic activity of MONCPT in preclinical melanoma mice model.
Yang XC; Tu CX; Luo PH; Zhu H; Zhu DF; Wu HH; Zhou XL; Lu W; He QJ; Yang B
Invest New Drugs; 2010 Dec; 28(6):800-11. PubMed ID: 19789842
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent.
Kang J; Kumar V; Yang D; Chowdhury PR; Hohl RJ
Eur J Pharm Sci; 2002 Mar; 15(2):163-70. PubMed ID: 11849913
[TBL] [Abstract][Full Text] [Related]
19. Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.
Sawant RR; Sawant RM; Torchilin VP
Eur J Pharm Biopharm; 2008 Sep; 70(1):51-7. PubMed ID: 18583114
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
Opanasopit P; Ngawhirunpat T; Chaidedgumjorn A; Rojanarata T; Apirakaramwong A; Phongying S; Choochottiros C; Chirachanchai S
Eur J Pharm Biopharm; 2006 Nov; 64(3):269-76. PubMed ID: 16870407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
